FindTrial
Sign In

Monitoring improvement of acne scars after treatment with Erbium laser.

Safety and efficacy of fractional ablative erbium laser with roller pixel in the treatment of post acne scars.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014433
Enrollment
30
Registered
2018-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Acne Scars

Interventions

Intervention1: Erbium-doped yttrium aluminium garnet laser: Fractional ablative laser with roller pixel 4 sessions, one month apart. Total duration- 4 months Control Intervention1: NOT APPLICABLE: NOT

Sponsors

DR PREETHI JOLLY
Lead Sponsor
DR PREETHI JOLLY
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing for the study. Patients more than 18 years of age. All the patients presenting with moderate to severe acne scarring. Patients who have not taken retinoids in the last 3 months.

Exclusion criteria

Exclusion criteria: Patients who are not willing for the study. Pregnant or lactating women. Patients with history of developing hypertrophic scars or keloids. Extensive active acne lesions or with secondary infection. Patients with concurrent herpes simplex infection.

Design outcomes

Primary

MeasureTime frame
Reduction of acne scars.Timepoint: Reduction of acne scars after one month of each session (4 sessions in total).—

Secondary

MeasureTime frame
Pain during session and post inflammatory pigmentation.Timepoint: To be assessed one month after each session (4 sessions in total)—

Countries

India

Contacts

Public ContactDR PREETHI JOLLY

FATHER MULLER MEDICAL COLLEGE

rameshderma@yahoo.com9845084224

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026